Ann Arbor, MINCT06929923Now EnrollingIRB Ready

Concussion, Mild Clinical Trial in Ann Arbor, MI

Access cutting-edge concussion, mild treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.

Sponsored by TecTraum Inc.

Quick Self-Assessment

See if you qualify for this Ann Arbor location

Preparing your pre-screening questions…

Expert Care in Ann Arbor

Access concussion, mild specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related concussion, mild treatment provided free

Apply for This Ann Arbor Location

Check if you qualify for this concussion, mild clinical trial in Ann Arbor, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Ann Arbor

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Ann Arbor site if eligible
  4. 4Begin participation

About This Concussion, Mild Study in Ann Arbor

This study is being conducted to determine the clinical safety and efficacy of Pro-2-Cool mediated head and neck cooling when applied after concussion and improved symptomatology among adolescent athletes as quantified by post-concussion symptom severity (PCSS) score.

Sponsor: TecTraum Inc.

Who Can Participate

Inclusion Criteria

Males and females, 13-21 years of age
Confirmed concussion diagnosis consistent with American Congress Rehabilitation Medicine guidelines 21, without any of the following:
Glasgow Coma Scale (GCS) score of less than 13 at 30 minutes post-injury
Loss of consciousness greater than 30 minutes
Post-traumatic amnesia lasting over 24 hours
Glasgow Coma Scale (GCS) ≥ 13 at the time of initial injury for study enrollment.
Post-Concussion Symptom Scale Score minimum of 15
Initial provider visit is within 7 days of injury
In generally good health as confirmed by medical history and determined by site investigator or designated trained healthcare professional under the supervision of the principal investigator.
Has informed consent obtained per protocol and as required per Institutional Review Board

Exclusion Criteria

Age \< 13 years or \> 21 years
Inability to understand the study requirements or provide informed consent
Cleared to return to play during initial visit
Prior participation in a Pro2Cool Clinical Study
Serious traumatic brain injury as evidenced by worsening symptoms:
Vomiting \> 2 episodes following injury
Hospitalization
Radiology scan indicating brain bleed
Slurred speech which has not resolved within 72 hours of concussive injury
Physical (e.g., head or neck injury that requires medical treatment) or mental disability hindering adequate response to assessment of symptoms
Hemodynamic instability/medical condition requiring further acute life-saving medical intervention
History of psychiatric disorder that includes suicide attempts within the last 6 months, unmanaged depression or anxiety, hospitalization for psychiatric treatment within the last 6 months
Known brain mass, intracranial hemorrhage, skull fracture
Scalp abnormalities including laceration or bleeding
Presence of ventriculoperitoneal (VP) shunt
Known hematological malignancies, including, but not limited to: multiple myeloma, leukemia, and lymphoma
Known history of Reynaud's Disease compromised liver function, cold agglutination, cold sensitivity, cryoglobulinemia, cryofibrinogenemia, and/or a history of severe migraines
Known or disclosed pregnancy or breast-feeding
Sustains another head or neck injury at the time of concussive injury which requires medical treatment

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Ann Arbor?

Yes, this clinical trial (NCT06929923) has an active research site in Ann Arbor, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Concussion, Mild Treatment Options in Ann Arbor, MI

If you're searching for concussion, mild treatment options in Ann Arbor, MI, this clinical trial (NCT06929923) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced concussion, mild specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all concussion, mild clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Ann Arbor, MI

See all heart attack clinical trials recruiting in Ann Arbor — not just this study.

Browse Heart Attack Trials in Ann Arbor

Ready to Join in Ann Arbor?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Ann Arbor, MI